We are exploring a new way to deliver treatment directly into tumors for patients with advanced melanoma on anti-PD1 therapy. This pilot study aims to see if this method improves outcomes.
Health conditions and diseases that the clinical trial is designed to study and treat.
Malignant melanoma is a type of skin cancer that develops from melanocytes, the pigment-producing cells in the skin. It can appear as a new mole or a change in an existing mole and may spread to other parts of the body if not treated early.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.